Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01924676 · ClinicalTrials.gov registry record · Phase 1

Food Effect And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers

A Phase 1 study of Healthy, sponsored by Pain Therapeutics.

Completed
Registry status
Phase 1
Development phase
18
Enrollment target
1
Study location

NCT01924676 is a Phase 1 study of Healthy that has completed, run by Pain Therapeutics. The registered enrollment target is 18 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01924676, a Phase 1 study of Healthy, has completed, sponsored by Pain Therapeutics.

COMPLETED
Registry status
Phase 1
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

To estimate the effects of food on oxycodone pharmacokinetics after administration of 40 mg doses of PF-00345439 Formulation K and to estimate its relative bioavailability compared to PF-00345439 Formulation X in the fasted state in healthy volunteers

Conditions Studied

Interventions

  • DRUG Oxycodone

Study Locations (1)

Maryland

  • Pfizer Investigational Site - Baltimore

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2013-08
Est. Completion 2013-10
Phase Phase 1

Sponsor

Pain Therapeutics

12 total trials

What the Registry Record Tells You About NCT01924676

The ClinicalTrials.gov registry entry for NCT01924676 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The listed sponsor is Pain Therapeutics, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Oxycodone is the first listed.

NCT01924676 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT01924676 about?

NCT01924676 is a clinical study titled "Food Effect And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers". To estimate the effects of food on oxycodone pharmacokinetics after administration of 40 mg doses of PF-00345439 Formulation K and to estimate its relative bioavailability compared to PF-00345439 Formulation X in the fasted state in healthy volunteers

What is the current status of trial NCT01924676?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2013-08. Estimated completion is 2013-10.

What conditions does trial NCT01924676 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT01924676?

The interventions under investigation include: Oxycodone (DRUG).

Who is sponsoring clinical trial NCT01924676?

This trial is sponsored by Pain Therapeutics, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01924676 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.